Alternatively, if you are unable to report the side effect electronically you can email your local Novartis Drug Safety Responsible person. Please select the location you are reporting from the list below. Select by location Select by locationAfghanistanAlbaniaAlgeriaAmericanSamoaAndorraAngolaAnguillaAntiguaandBarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosniaandHerzegovinaBotswanaBrazilBruneiDarussalamBulgariaBurkinaFasoBurundiCambodiaCameroonCanadaCape VerdeCaymanIslandsCentralAfricanRepublicChadChileChinaChristmasIslandCocos(Keeling)IslandsColombiaComorosCongoCongo, The Democratic Republic OfCostaRicaCôteD'ivoireCroatiaCubaCuraçaoCyprusCzechRepublicDenmarkDjiboutiDominicaDominicanRepublicEcuadorEgyptElSalvadorEquatorialGuineaEritreaEstoniaEthiopiaFijiFinlandFranceFrenchGuianaFrenchPolynesiaGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuamGuatemalaGuineaGuinea-BissauGuyanaHaitiHolySee(VaticanCityState)HondurasHongKongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJordanKazakhstanKenyaKorea,SouthKuwaitKyrgyzstanLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMauritaniaMauritiusMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNewCaledoniaNew ZealandNicaraguaNigerNigeriaNorwayOmanPakistanPalestinianTerritoryPanamaPapuaNewGuineaParaguayPeruPhilippinesPolandPortugalPuertoRicoQatarRomaniaRussianFederationRwandaSaintHelenaSaintKittsAndNevisSaintLuciaSaintMartin(FrenchPart)SaintVincentAndTheGrenadinesSanMarinoSao Tome & PrincipeSaudiArabiaSenegalSerbiaSeychellesSierraLeoneSingaporeSlovakiaSloveniaSomaliaSouthAfricaSpainSri-LankaSudanSurinameSwazilandSwedenSwitzerlandSyrianArabRepublicTaiwanTajikistanTanzaniaThailandTogoTrinidadAndTobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsUgandaUkraineUnitedArabEmiratesUnitedKingdomUnitedStatesUruguayUzbekistanVenezuelaVietNamVirginIslands, USVirginIslands, BritishYemenZambiaZimbabwe Contact information Afghanistan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Albania When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Algeria When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information American Samoa When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Andorra When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Angola When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Anguilla When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Antigua and Barbuda When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Argentina When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Armenia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Aruba When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Australia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Austria When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Azerbaijan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bahamas When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bahrain When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bangladesh When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Barbados When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Belarus When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Belgium When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Belize When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Benin When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bermuda When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bhutan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bolivia, Plurinational state of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bosnia and Herzegovina When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Botswana When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Brazil When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Brunei Darussalam When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Bulgaria When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Burkina Faso When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Burundi When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cambodia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cameroon When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Canada When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cape Verde When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cayman Islands When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Central African Republic When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Chad When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Chile When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information China When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Christmas Island When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cocos (Keeling) Islands When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Colombia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Comoros When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Congo When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Congo, The Democratic Republic Of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Costa Rica When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Croatia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cuba When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Curaçao When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Cyprus When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Czech Republic When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Côte D'ivoire When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Denmark When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Djibouti When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Dominica When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Dominican Republic When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Ecuador When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Egypt When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information El Salvador When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Equatorial Guinea When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Eritrea When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Estonia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Ethiopia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Fiji When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Finland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities unless local legal regulations require to do so. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information France When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information French Guiana When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information French Polynesia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Gabon When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Gambia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Georgia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Germany When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Ghana When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Gibraltar When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Greece When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Greenland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Grenada When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Guam When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Guatemala When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Guinea When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Guinea-Bissau When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Guyana When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Haiti When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Holy See (Vatican City State) When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Honduras When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Hong Kong When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Hungary When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Iceland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information India When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Iraq When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Ireland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Israel When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Italy When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Jamaica When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Jordan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Kazakhstan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Kenya When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Indonesia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Iran, Islamic Republic Of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Korea, Republic of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Kuwait When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Kyrgyzstan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Latvia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Lebanon When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Lesotho When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Liberia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Libya When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Liechtenstein When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Lithuania When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Luxembourg When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Macao When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Macedonia, The Former Yugoslav Republic Of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Madagascar When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Malawi When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Malaysia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Maldives When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Mali When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Malta When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Mauritania When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Mauritius When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Mexico When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Moldova, Republic Of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Monaco When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Mongolia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Montenegro When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Montserrat When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Morocco When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Mozambique When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Namibia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Nauru When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Nepal When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Netherlands When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information New Caledonia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information New Zealand When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Nicaragua When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Niger When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Nigeria When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Norway When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Oman When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Pakistan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Palestinian Territory, Occupied When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Panama When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Papua New Guinea When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Paraguay When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Peru When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Philippines When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Poland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Portugal When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Puerto Rico When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Qatar When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Romania When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Russian Federation When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Rwanda When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Saint Helena, Ascension And Tristan Da Cunha When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Saint Kitts And Nevis When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Saint Lucia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Saint Martin (French Part) When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Saint Vincent And The Grenadines When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information San Marino When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Sao Tome & Principe When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Saudi Arabia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). Patient Safety Department - Novartis Pharma AG - Saudi Arabia: Toll free phone: 8001240078 Phone: +966112658100 Fax: +966112658107 Email: [email protected] Contact information Senegal When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Serbia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Seychelles When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Sierra Leone When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Singapore When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Slovakia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Slovenia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Somalia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information South Africa When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Spain When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Sri Lanka When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Sudan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Suriname When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Swaziland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Sweden When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Switzerland When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Syrian Arab Republic When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Taiwan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Tajikistan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Tanzania, United Republic Of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Thailand When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Togo When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Trinidad And Tobago When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Tunisia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Turkey When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Turkmenistan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Uganda When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Ukraine When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information United Arab Emirates When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information United Kingdom When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). Country Of incidence: Please specify the country of incidence; Great Britain (GB) or Northern Ireland (NI) [email protected] Contact information United States When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Uruguay When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Uzbekistan When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Venezuela, Bolivarian Republic Of When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Viet Nam When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Virgin Islands, British When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Virgin Islands, U.S. When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Yemen When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Zambia When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Zimbabwe When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] Contact information Turks and Caicos Islands When submitting in an e-mail format please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws: Name of the drug:Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the side effect. The side effect associated with the drug:Symptom evolution over time. Description of any treatment needed for the side effect. Name of healthcare provider who provided treatment and contact information. Your name (optional):Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Novartis or its agents may contact you for further information about the side effect. If you do not wish to be contacted, you should indicate this in your email. Information about the person who experienced the side effect:Any other medical conditions currently ongoing. Medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional). [email protected] * Math question 6 + 13 = Solve this simple math problem and enter the result. E.g. for 1+3, enter 4. Print Save English Français Português Español العربية 简体中文
